Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert M Fox

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Healthcarepapers|June 18, 2003
Academic health sciences centres laid bareJeffrey C Lozon, Robert M Fox
Transfusion|March 7, 2013
Microbial contamination of hematopoietic progenitor and other regenerative cells used in transplantation and regenerative medicineMichael R Jacobs, Caryn E Good, Robert M Fox, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|April 7, 2018
Feasibility of mesenchymal stem cell culture expansion for a phase I clinical trial in multiple sclerosisSarah M Planchon, Karen T Lingas, Jane Reese Koç, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 31, 2004
High-dose carmustine, etoposide, and cisplatin for autologous stem cell transplantation with or without involved-field radiation for relapsed/refractory lymphoma: an effective regimen with low morbidity and mortalityPunit D Wadhwa, Pingfu Fu, Omer N Koc, et al.
British Journal of Haematology|October 4, 2007
Influence of human leucocyte antigen disparity and graft lymphocytes on allogeneic engraftment and survival after umbilical cord blood transplant in adultsWillem J van Heeckeren, Laura R Fanning, Howard J Meyerson, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Healthcarepapers|June 18, 2003
Academic health sciences centres laid bareJeffrey C Lozon, Robert M Fox
Transfusion|March 7, 2013
Microbial contamination of hematopoietic progenitor and other regenerative cells used in transplantation and regenerative medicineMichael R Jacobs, Caryn E Good, Robert M Fox, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|April 7, 2018
Feasibility of mesenchymal stem cell culture expansion for a phase I clinical trial in multiple sclerosisSarah M Planchon, Karen T Lingas, Jane Reese Koç, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 31, 2004
High-dose carmustine, etoposide, and cisplatin for autologous stem cell transplantation with or without involved-field radiation for relapsed/refractory lymphoma: an effective regimen with low morbidity and mortalityPunit D Wadhwa, Pingfu Fu, Omer N Koc, et al.
British Journal of Haematology|October 4, 2007
Influence of human leucocyte antigen disparity and graft lymphocytes on allogeneic engraftment and survival after umbilical cord blood transplant in adultsWillem J van Heeckeren, Laura R Fanning, Howard J Meyerson, et al.
Pageof 1